HH Biotechnology Holdings Company
HHBTOTCReal Estate● Active
$0.00
+$0.00(+0.00%)
Market Cap$1406
P/E Ratio—
52W High$0.0002
52W Low$0.0001
HH Biotechnology Holdings Company（HHBT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · HHBT · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2015-12 |
|---|---|
| Revenue | |
| Revenue | $7.99M |
| Cost of Revenue | $5.64M |
| Gross Profit | $2.35M |
| Gross Margin %(computed) | 29.45% |
| Operating Expenses | |
| R&D Expenses | $0.00M |
| G&A Expenses | $0.00M |
| Total Operating Expenses | ($0.75M) |
| Operating Income | $3.10M |
| Operating Margin %(computed) | 38.78% |
| Interest Income | $0.00M |
| Interest Expense | $0.87M |
| Income Before Tax | $2.66M |
| Income Tax Expense | $0.23M |
| Net Income | $2.48M |
| Net Margin %(computed) | 30.99% |
| Per Share & EBITDA | |
| EPS (Basic) | $0.18 |
| Wtd Avg Shares | 13.52M |
| EBITDA | $5.44M |
| EBITDA Margin %(computed) | 68.13% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解HH Biotechnology Holdings Company
关于HH Biotechnology Holdings Company（HHBT）损益表
HH Biotechnology Holdings Company（HHBT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2015财年，HHBT实现营收$0.01B，毛利润$0.00B（毛利率29.45%），净利润$0.00B（净利率30.99%）。
常见问题
HHBT · 4 问HH Biotechnology Holdings Company（HHBT）2015财年营收为$0.01B，同比down—%。
HHBT revenueHHBT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09